SMARCB1 and rhabdoid tumor: Lee et al. demonstrated that AT/RT has an extremely low rate of recurring mutations in the genome, while hSNF5 inactivation is the main and sole recurrent genetic event involved in rhabdoid tumor development, as observed by whole‐exome sequencing analysis and single nucleotide polymorphisms array analysis.83